Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Spatial Frequency Domain Imaging as an Objective Quantification of Longitudinal Skin Changes in Scleroderma

NCT07090226 is registered in ClinicalTrials.gov with Boston University as lead sponsor.

NCT NCT07090226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Spatial Frequency Domain Imaging as an Objective Quantification of Longitudinal Skin Changes in Scleroderma
Lead sponsor
Boston University
Phase
Not applicable
Overall status
Recruiting
Start date
November 6, 2025
Completion date
December 31, 2028
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse cutaneous scleroderma, systemic scleroderma